Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra for fever during neutropenia and mucositis after autologous stem cell transplantation in multiple myeloma
2018-005046-10Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Jul 2019
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of anakinra in febrile neutropenia (FN) and stomatitis (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Incidence of fever during neutropenia. Started Jul 2019; status: completed.
02
Drugs
anakinra
03
Conditions
febrile neutropenia (FN)stomatitis
Beyond the preview
Go deeper on 2018-005046-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-005046-10.